Gainers
- VistaGen Therapeutics VTGN shares rose 37.6% to $0.18 during Wednesday's pre-market session. The market value of their outstanding shares is at $40.3 million.
- 89bio ETNB shares moved upwards by 33.85% to $14.63. The market value of their outstanding shares is at $764.1 million.
- Midatech Pharma MTP shares moved upwards by 17.83% to $0.42. The company's market cap stands at $2.9 million.
- Lyell Immunopharma LYEL stock increased by 17.2% to $2.58. The company's market cap stands at $643.6 million.
- Telesis Bio TBIO stock moved upwards by 15.83% to $2.56. The market value of their outstanding shares is at $75.5 million. As per the news, the Q4 earnings report came out yesterday.
- Shuttle Pharmaceuticals SHPH shares moved upwards by 13.66% to $1.58. The company's market cap stands at $21.5 million.
Losers
- Novo Integrated Sciences NVOS stock fell 12.1% to $0.12 during Wednesday's pre-market session. The company's market cap stands at $16.9 million.
- Pear Therapeutics PEAR shares decreased by 11.29% to $0.3. The market value of their outstanding shares is at $41.6 million.
- Qualigen Therapeutics QLGN shares decreased by 7.9% to $1.05. The market value of their outstanding shares is at $4.4 million.
- Tivic Health Systems TIVC shares fell 7.13% to $0.17. The company's market cap stands at $5.1 million.
- Paratek Pharmaceuticals PRTK stock declined by 6.99% to $1.73. The company's market cap stands at $99.0 million. As per the news, the Q4 earnings report came out 4 days ago.
- Connect Biopharma Hldgs CNTB stock fell 6.78% to $1.1. The company's market cap stands at $60.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ETNB89bio Inc
$7.94-0.63%
LYELLyell Immunopharma Inc
$0.62802.01%
NVOSNovo Integrated Sciences Inc
$0.03707.22%
QLGNQualigen Therapeutics Inc
$3.90-3.47%
SHPHShuttle Pharmaceuticals Holdings Inc
$0.799911.9%
TBIOTelesis Bio Inc
$0.3800-9.52%
TIVCTivic Health Systems Inc
$0.300033.7%
VTGNVistagen Therapeutics Inc
$2.55-0.80%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in